Skip to main content
Article thumbnail
Location of Repository

Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1

By Frédéric Mouquet, François Cuilleret, Sophie Susen, Karine Sautière, Philippe Marboeuf, Pierre Vladimir Ennezat, Eugène McFadden, Pascal Pigny, Florence Richard, Bernadette Hennache, Marie Christine Vantyghem, Michel Bertrand, Jean Dallongeville, Brigitte Jude and Eric Van Belle
Topics: Clinical Research
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.
  2. (1999). Age-dependent impairment of angiogenesis. Circulation
  3. (1999). Angiographic methods to assess human coronary angiogenesis.
  4. (2008). Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol
  5. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol
  6. (2001). Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation
  7. (1999). Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol
  8. (2002). Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis
  9. (1998). Coronary collaterals in patients with normal and impaired left ventricular systolic function.
  10. (2003). Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation
  11. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects.
  12. Downregulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors.
  13. (1999). Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation
  14. Endothelial progenitor cells as putative targets for angiostatin.
  15. (2001). Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol
  16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report
  17. High blood pressure is inversely related with the presence and extent of coronary collaterals.
  18. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.
  19. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  20. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus.
  21. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.
  22. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway.
  23. (2003). Measurement of observer agreement. Radiology
  24. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res
  25. (2003). Patients with coronary collaterals and normal left ventricular systolic function: clinical, hemodynamic, and angiographic characteristics.
  26. (2006). Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1). Cardiovasc Res
  27. (2005). Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease. Diabetes Care
  28. (2006). Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol
  29. Relation between collateral flow assessed by Doppler guide wire and angiographic collateral grades. Am Heart J 1995;130:32–37. MS and collateral vessel formation in patients with documented occluded coronary arteries 849
  30. (1999). Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.
  31. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
  32. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
  33. The metabolic syndrome vis-a-vis syndrome of insulin resistance: the perfect squall.
  34. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
  35. Tissue inhibition of angiotensinconverting enzyme activity stimulates angiogenesis in vivo.
  36. (2000). Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.